Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Inno

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 21, 2017
Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic reviewFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Critical Reviews in Oncology/Hematology|October 22, 2019
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapyStefania Gori, Alessandro Inno, Lorenzo Belluomini, et al.
Critical Reviews in Oncology/Hematology|August 3, 2021
Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysisAlessandro Inno, Giandomenico Roviello, Antonio Ghidini, et al.
Clinical Nuclear Medicine|May 11, 2016
18F-NaF PET/CT Imaging of Brain MetastasesMatteo Salgarello, Gianluigi Lunardi, Alessandro Inno, et al.
Drug Target Insights|October 16, 2023
First-line tepotinib for a very elderly patient with metastatic NSCLC harboring <i>MET</i> exon 14 skipping mutation and high PD-L1 expressionAlessandro Inno, Giuseppe Bogina, Giulio Settanni, et al.
Critical Reviews in Oncology/Hematology|April 16, 2021
Current treatment options for HER2-positive breast cancer patients with brain metastasesDaniele Galanti, Alessandro Inno, Maria La Vecchia, et al.
Drug Target Insights|July 6, 2023
Activity of sotorasib against brain metastases from NSCLC harboring <i>KRAS</i> p.G12C mutation: a case reportAlessandro Inno, Fabiana Marchetti, Matteo Valerio, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Tumori|May 23, 2022
Adherence to oral hormonal anticancer agents in breast cancerStefania Gori, Alessandra Modena, Jennifer Foglietta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Borderline resectable pancreatic cancer: More than an anatomical conceptFausto Petrelli, Alessandro Inno, Sandro Barni, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|June 21, 2017
Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic reviewFausto Petrelli, Alessandro Inno, Antonio Ghidini, et al.
Critical Reviews in Oncology/Hematology|October 22, 2019
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapyStefania Gori, Alessandro Inno, Lorenzo Belluomini, et al.
Critical Reviews in Oncology/Hematology|August 3, 2021
Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysisAlessandro Inno, Giandomenico Roviello, Antonio Ghidini, et al.
Clinical Nuclear Medicine|May 11, 2016
18F-NaF PET/CT Imaging of Brain MetastasesMatteo Salgarello, Gianluigi Lunardi, Alessandro Inno, et al.
Drug Target Insights|October 16, 2023
First-line tepotinib for a very elderly patient with metastatic NSCLC harboring <i>MET</i> exon 14 skipping mutation and high PD-L1 expressionAlessandro Inno, Giuseppe Bogina, Giulio Settanni, et al.
Critical Reviews in Oncology/Hematology|April 16, 2021
Current treatment options for HER2-positive breast cancer patients with brain metastasesDaniele Galanti, Alessandro Inno, Maria La Vecchia, et al.
Drug Target Insights|July 6, 2023
Activity of sotorasib against brain metastases from NSCLC harboring <i>KRAS</i> p.G12C mutation: a case reportAlessandro Inno, Fabiana Marchetti, Matteo Valerio, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Tumori|May 23, 2022
Adherence to oral hormonal anticancer agents in breast cancerStefania Gori, Alessandra Modena, Jennifer Foglietta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Borderline resectable pancreatic cancer: More than an anatomical conceptFausto Petrelli, Alessandro Inno, Sandro Barni, et al.
Pageof 11